Dopamine and the aberrant salience hypothesis of schizophrenia

World Psychiatry

Volumn 15, Issue 1, 2016, Pages 3-4

  Howes, Oliver D ^a,b   Nour, Matthew M ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

AVERSION; BRAIN ELECTROPHYSIOLOGY; DELUSIONAL DISORDER; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; EDITORIAL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTIVATION; NONHUMAN; PARANOIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PRODROMAL SYMPTOM; PROTEIN FUNCTION; PSYCHOSIS; REWARD; SALIENCE NETWORK; SCHIZOPHRENIA; SENSORY STIMULATION; SIGNAL TRANSDUCTION; VENTRAL STRIATUM; VENTRAL TEGMENTUM;

EID: 84964939516     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20276     Document Type: Editorial

References (15)

1. Howes OD, Kambeitz J, Kim E et al. Arch Gen Psychiatry 2012;69:776-86.
2. Kapur S. Am J Psychiatry 2003;160:13-23.
3. Fletcher PC, Frith CD. Nat Rev Neurosci 2009;10:48-58.
4. Berridge KC Eur J Neurosci 2012;35:1124-43.
5. Bromberg-Martin ES, Matsumoto M, Hikosaka O. Neuron 2010;68:815-34.
6. Howes OD, Kapur S. Schizophr Bull 2009;35:549-62.
7. Howes OD, Williams M, Ibrahim K et al. Brain 2013;136:3242-51.
8. Egerton A, Chaddock CA, Winton-Brown TT et al. Biol Psychiatry 2013;74: 106-12.
9. Howes O, Bose S, Turkheimer F et al. Mol Psychiatry 2011;16:885-8.
10. Jaspers K. General psychopathology. Baltimore: Johns Hopkins University Press, 1997.
11. Garety PA, Kuipers E, Fowler D et al. Psychol Med 2001;31:189-95.
12. Peters E, Ward T, Jackson M et al. World Psychiatry 2016;15:41-52.
13. Murray GK, Corlett PR, Clark L et al. Mol Psychiatry 2008;13:267-76.
14. Roiser JP, Stephan KE, den Ouden HEM et al. Psychol Med 2009;39:199-209.
15. Hägele C, Schlagenhauf F, Rapp M et al. Psychopharmacology 2015;232: 331-41.